Authors: Van der Veen, AH Ten Hagen, TLM De Wilt, JHW Van Ijken, MGA Eggermont, AMM

Citation: Ah. Van Der Veen et al., An overview on the use of TNF-alpha: Our exprerience with regional administration and developments towards new opportunities for systemic application, ANTICANC R, 20(5B), 2000, pp. 3467-3474

Authors: De Wilt, JHW Soma, GI Ten Hagen, TLM Kanou, J Takagi, K Nooijen, PTGA Seynhaevel, ALB Eggermont, AMM

Citation: Jhw. De Wilt et al., Synergistic antitumour effect of TNF-SAM2 with melphalan and doxorubicin in isolated limb perfusion in rats, ANTICANC R, 20(5B), 2000, pp. 3491-3496

Authors: Manusama, ER De Wilt, JHW Ten Hagen, TLM Marquet, RL Eggermont, AMM

Citation: Er. Manusama et al., Toxicity and antitumor activity of interferon gamma alone and in combinations with TNF alpha and melphalan in isolated limb perfusion in the BN175 sarcoma tumor model in rats, ONCOL REP, 6(1), 1999, pp. 173-177

Authors: Aalbers, AGJ De Wilt, JHW Zondervan, PE Ijzermans, JNM

Citation: Agj. Aalbers et al., A colon-derived inflammatory pseudotumor, DIG DIS SCI, 44(3), 1999, pp. 578-581